NIH

Ahead of World Cancer Day on February 4, the American Association for Cancer Research (AACR) would like to thank the thousands of laboratory researchers, physician-scientists, healthcare professionals and patient advocates around the globe and recognize their commitment to increasing the number of cancer survivors who are alive today. In the U.S., thanks to decades of federally funded cancer research supported by the National Institutes of Health (NIH) and the National Cancer Institute (NCI), we have seen a steady rise in the number of Americans who survive a cancer diagnosis. Our continued commitment to preventing and curing cancer comes at a time when, despite all the incredible progress...
This article is the second in a series highlighting the accomplishments of Research!America’s 2017 Advocacy Award honorees who will be saluted at a dinner in Washington, D.C., on March 15. More details can be found here . Anthony S. Fauci, M.D., is Research!America’s recipient of the Legacy Award , which honors an individual’s outstanding commitment to sustaining our nation’s world-class leadership in medical and health research. Dr. Fauci is the director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). An effective communicator, Dr. Fauci has testified before Congress more than 250 times, voicing strong support for biomedical...
January is Glaucoma Awareness Month, and March 12-17 will be World Glaucoma Week (WGW) with events held around the globe, including an Alliance for Eye and Vision Research (AEVR) Congressional Briefing on March 9 at noon in House Rayburn Office Building 2040 in Washington, D.C. Americans fear vision loss more than most other conditions, as reported in a 2014 Research!America survey conducted for AEVR. 1 So sustained education about glaucoma is vital since it is the second leading cause of preventable vision loss in the United States. A neurological disease affecting the optic nerve, it causes loss of peripheral vision and ultimately blindness. It affects more than 2.7 million Americans over...
Dear Research Advocate, Tomorrow, our 45th U.S. President will be inaugurated. The challenge and opportunity that President Trump - and all our elected representatives - face is to ensure that the next four years deliver better health, safety and prosperity. I hope President Trump’s inaugural address signals that his Administration will leverage research and innovation to meet our nation’s normative and strategic objectives. With NIH, CDC, AHRQ and FDA under the purview of the Department of Health and Human Services, the new Secretary will influence the nature and pace of medical progress, the capability of our public health infrastructure, and other critical science-relevant variables in...
New leadership in the White House means new leadership in key government positions such as those at the National Institutes of Health (NIH), which houses the Transdisciplinary Collaborative Centers (TCC) for Health Disparities Research Program. TCC supports academic, community, and government coalitions that research social determinants and analyze various health- or non-health-related policies that affect health disparities. Social determinants, such as education, income, and community conditions — which are often tied to race and ethnicity — play a significant role in why certain communities experience higher rates of infant mortality , diabetes , stroke , obesity , and breast cancer...
Dear Research Advocate, On Tuesday, I had the great honor of attending the bill signing for the 21st Century Cures Act (21stCC). It was particularly meaningful that this bill crossed the finish line during Vice President Biden’s tenure. His determination to deliver other families from the cancer tragedy experienced by his own lent a special strength to our collective efforts over a protracted period of congressional debate. If we continue to channel the Vice President’s level of commitment and determination, we can ensure that achieving faster medical progress remains at the forefront of national priorities. As you know (but it never hurts to reaffirm), it is important, but not sufficient,...
Tweet Follow @ResearchAmerica Six science-savvy teams comprised of researchers from around the globe are currently in the running for a grand prize of $230,000 to develop new big data methods for advancing biomedical research. The two-phased Open Science Prize contest was made possible through a collaboration between the National Institutes of Health (NIH) , the Wellcome Trust and the Howard Hughes Medical Institute . During the first phase, the teams received prize money to help create tools or services that could be used to tackle important issues in biomedicine and improve health. They designed prototypes to address subjects such as neuroimaging, rare diseases, mental and neurological...
Dear Research Advocate, As we prepare to celebrate Thanksgiving, it is fitting to thank our public health workforce for their tireless efforts on our behalf every day of the year. Monday marked the official Public Health Thank You Day (PHTYD), but it is ongoing. This year’s effort has been extraordinary, with more than 50 organizations partnering with us to get the word out. For the first time since we launched PHTYD in 2005, Congress officially joined the effort. As I mentioned last week, the co-chairs of the House Public Health Caucus introduced a resolution supporting PHTYD. Online, more than 1,000 organizations and individuals participated, including federal officials from HHS and DOD,...
A new report prepared by leading scientists, thought leaders and policy experts, A Vision and Pathway for NIH , includes recommendations for the new Administration to further advance the nation’s leading biomedical research and health agency-- the National Institutes of Health (NIH). The goal is to better align agency organization and policies with present and future strategies for achieving the highest impact in research and training, and improving health outcomes. The report, written by an ad hoc working group, led by Research!America board member Keith Yamamoto, Ph.D., Vice Chancellor for Science Policy and Strategy; Director, UCSF Precision Medicine; Vice Dean for Research, School of...
Dear Research Advocate: A very close election has entered the history books, in the process laying bare the profound divisions that will challenge all our elected representatives as they seek to unify and heal the nation. We have been deluged with questions about the impact of a Trump Administration on science. A useful primer is his answers to the ScienceDebate.org questionnaire that we and several other groups worked together to create. For example, President-elect Trump says this: “...the federal government should encourage innovation in the areas of space exploration and investment in research and development across the broad landscape of academia.” He also says this: “Though there are...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter